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Abstract
Exposed to the blood milieu and variable hemodynamic forces, endothelial cells of differ-
ent vessels exhibit significant heterogeneity, directing also the variety of endothelial func-
tions. Endothelial cells are actively involved in many physiological processes, including 
vascular tone regulation, fluid filtration and reabsorption processes, maintenance of blood 
fluidity and proper hemostasis, leucocyte trafficking, tissue repair, and angiogenesis; 
accordingly, healthy endothelium is crucial for vascular homeostasis. On the other hand, 
many exo- and endogenous harmful factors can cause endothelial dysfunction, associated 
with inflammation, thrombosis, pathological vascular wall remodeling, and predispos-
ing to the development of cardiovascular and other diseases. In order to design accurate 
clinical and pharmacological strategies to postpone or ameliorate endothelial dysfunction, 
endothelial dysfunction should firstly be recognized. Therefore, understanding endothe-
lial physiology is crucial for clinical measures to be timely taken. The review briefly out-
lines some basic concepts of endothelial structure and function, focusing on endothelial 
barrier function and endothelium-dependent vasodilation, and addressing some potential 
therapeutic targets. Additional specific concepts of endothelial (dys)function, with par-
ticular emphasis on its involvement in inflammation, hemostasis, and its (mal)adaptation 
to environmental challenges are extensively described in the following book chapters.
Keywords: endothelium, endothelial cells, endothelial dysfunction, vascular tone 
regulation, nitric oxide, capillary permeability, cardiovascular diseases, oxidative stress
1. Introduction: general concepts
Endothelium, composed of approximately one trillion endothelial cells and extending over 
an area of 300 m2 [1, 2], is a monolayer cell lining covering the luminal surface of blood and 
lymphatic vessels, and the heart. Its strategic position, being in a direct contact with the blood 
on one side and with the underlying tissues on the other, enables its communication with 
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blood elements and the adjacent cells. Developmentally, it arises from mesoderm via the 
differentiation of hemangioblasts and angioblasts [3]. However, other cell lineages, such as 
adipose lineage and mesenchymal cells, can transdifferentiate into endothelial cells even in 
adulthood [4, 5].
Besides presenting a mechanical barrier between the blood and the tissues, the endothelium is 
actively involved in various processes, including the regulation of vascular tone, maintaining 
blood fluidity, and enabling proper hemostasis when needed, in leucocyte trafficking, inflam-
mation, wound repair, and angiogenesis, and, therefore, is of crucial importance for vascular 
homeostasis. As it metabolizes and releases many physiologically active substances that by 
acting in auto-, para-, and endocrine manner, govern the above physiological processes, it 
might justified be called an endocrine organ.
1.1. Endothelial heterogeneity
Although stemming from the same ontogenetic origin, to fulfill different metabolic and 
functional demands of tissues, the endothelial cells of different tissues exhibit distinct phe-
notypic and morphologic characteristics, accounting for its huge molecular and functional 
heterogeneity.
Endothelial heterogeneity could also be explained by the diversity of the vessel networks it 
is part of, namely arteries, veins, and capillaries which all serve different functions. While the 
endothelium of arteries and veins forms a continuous layer, it can be continuous, fenestrated, 
or discontinuous in capillaries, directing endothelial permeability and thus the degree of the 
filtration and reabsorption in the corresponding tissue. The representative tissues with the con-
tinuous non-fenestrated type of endothelium include the brain, the skin, the lung, and the 
heart; the continuous fenestrated type is found in tissues exhibiting extensive transcapillary 
transport: exo- and endocrine glands, the intestine mucosa, and the kidney glomeruli, whereas 
the prototype of the discontinuous endothelium are sinusoids in the liver and bone marrow 
vascular beds [1]. Endothelial cells of certain capillary beds, concomitantly with the adjacent 
tissue cells form specialized structures such as the blood-brain barrier composed of the brain 
capillary endothelial cells and the adjacent astrocytes, or special communications between 
maternal endothelial cells of the spiral arteries and fetal trophoblast cells in placenta [6].
While the thin capillary walls (of 0.2 μm order of magnitude) are composed only of endothe-
lial cells anchored in their basal lamina (and surrounded by pericytes), in larger vessels, endo-
thelium is part of the much thicker vascular wall. The latter comprises also the beneath lying 
vascular smooth muscle cells (VSMC) of arteries and veins, respectively, and the perivascular 
cells including macrophages and mesenchymal cells from the vessel adventitia.
It has been appreciated that the endothelial lining of arteriolar vascular beds primarily affects 
vascular tone and thus vascular resistance regulation, adjusted to tissue demands. Capillary 
endothelium in turn mainly determines water and solute passage into the tissues, whereas 
the one in the postcapillary venules directs vascular permeability and blood cell trafficking, 
being more involved in immune and inflammatory processes governing tissue repair and 
angiogenesis [7]. Therefore, apart from inter-endothelial cell junctions influencing capillary 
permeability, mutual communication of endothelial cells with other elements of the vascular 
wall importantly contributes to vascular homeostasis [8].
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The vast heterogeneity of the endothelium of arteries and veins could additionally be 
explained by significantly different physiological and physical conditions to which endothe-
lial cells of various vascular beds are exposed, such as blood pressure, shear stress, and pulsa-
tility. Hemodynamic forces significantly impact endothelial structure and function: compared 
to ellipsoid morphology and coaxial alignment under the conditions of laminar flow, cell 
morphology and alignment change drastically in the settings of turbulent flow and at vessel 
bifurcations, all predisposing to atherogenicity [9, 10].
Endothelial cells therefore exhibit a wide range of plasticity, from alterations in the expression 
of various membrane receptors and adhesion molecules, changes in their morphology and 
shape, their mitogenic potential and even their potential to migrate or transit into different 
cell types (endothelial-to-mesenchymal transition) [3, 11].
1.2. Endothelial dysfunction
Being directly exposed to intravascular milieu, it is obvious that the composition of blood and 
the (patho)physiological conditions strongly affect endothelial cells, in terms of mediating 
signals which directly target their surface and activate numerous intracellular signaling path-
ways. During our life span, we are exposed to a variety of risk factors and toxic and noxious 
stimuli from the external environment (including air pollutants, tobacco smoke, chemicals 
from food, radiation, different eating habits in terms of high salt, sugar or saturated fatty acids 
intake, etc.) which strongly impact endothelial cells and their functions. As such, endothelial 
cells are constantly being challenged by changing internal environment to which they adapt 
more or less successfully. As long as their adaptive capacity in terms of maintaining homeo-
stasis between vasoconstrictors and vasodilators reflecting vascular tone regulation; anti- and 
procoagulant activity reflecting hemostatic processes; anti- and pro-inflammatory mediators 
affecting the inflammatory response, and pro- and antiangiogenic factors affecting new vessel 
formation, remains in physiological limits, one might consider the endothelium to be healthy. 
However, the delineation between health and disease is not easy to define. When the mal-
adaptive patterns overweigh, endothelial dysfunction issues what leads to disease [12].
Although the mostly exposed clinical sign of endothelial dysfunction is impaired endothe-
lium-dependent vasodilation, endothelial dysfunction on a broader scale encompasses a 
pro-inflammatory, proadhesive, procoagulant, and proliferative state predisposing to athero-
sclerosis [13]. Multiple mechanisms have been involved in the development of endothelial 
dysfunction, connected to alterations in glucose and lipid metabolism, insulin resistance, 
obesity, dyslipidemia, hyperhomocysteinemia, altered hormone and cytokine secretion, 
imbalance in the autonomic nervous system activity, arterial hypertension, etc. Oxidative 
stress is acknowledged to play a central role in the development of endothelial dysfunction; 
moreover, oxidative stress has been appreciated as one of the main factors involved in normal 
aging, which imminently is also associated with endothelial dysfunction [14]. Although the 
severity of endothelial dysfunction might differ between vascular beds, independent studies 
have shown correlations between endothelial dysfunction in different vascular beds [13, 15]. 
Therefore, endothelial dysfunction can be regarded as a systemic disorder: as tissues and 
organs depend on proper vascularization and an adequate supply of nutrients and removal 
of waste products, the dysfunctional endothelium not only predisposes to the development 
of cardiovascular diseases (atherosclerosis, hypertension, peripheral arterial disease, stroke, 
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etc.) but also to a wide range of other diseases, including metabolic (diabetes, obesity), inflam-
matory, rheumatoid, oncology, and degenerative diseases, and in the worst scenario, culmi-
nates in organ failure.
Accordingly, understanding the physiology of the endothelium is of crucial clinical impor-
tance, and there is an ongoing search for potential strategies to postpone or at least amelio-
rate endothelial dysfunction and disease progression, either in terms of drugs application or 
avoiding the known risk factors; even more, when timely treated, endothelial dysfunction 
might be reversible [13]. To this end, additional methodological tools have to be accom-
plished in order to timely detect potential endothelial dysfunction. In spite of huge effort 
put in mechanistic studies performed on animal models and cell cultures, the exact tool to 
specifically reveal endothelial dysfunction clinically is missing and, at the moment, is far 
from being optimal. Various molecules have been used as surrogate markers of endothelial 
function, including soluble vascular adhesion molecule-1 (sVCAM-1), von Willebrand fac-
tor (vWF), angiopoietin-2 [16], adipocytokines [17], microparticles [18], and several more; 
yet, they mostly lack the sensitivity and specificity, and are often too robust to detect subtle 
preclinical changes. Also functional studies to assess endothelium, such as measurement of 
arterial intima-media thickness or flow-mediated dilation (FMD), offer just a raw estimation 
of endothelial function. As proper organ functioning strongly depends on microcirculation, 
particular attention should be given to this vascular bed also in the clinics. An interesting 
observation when tracing the microcirculation in vivo is that it exhibits typical oscillations of 
distinct frequencies [19, 20]. It has been suggested that each of them could reflect particular 
aspect of vascular tone regulation: low frequency oscillations have shown good correlations 
with the endothelial component of vascular tone regulation and therefore could be used as a 
marker of microvascular endothelial function [19].
Endothelium represents a therapeutic potential: many newer drugs targeting endothelium—
either its surface and the corresponding membrane receptors, or intracellular targets affecting 
various signaling or metabolic pathways or directly its genome, are being developed and 
tested on the level of preclinical and clinical studies. In addition, independent studies have 
also shown that many classical cardiovascular drugs, such as angiotensin receptor antago-
nists, calcium (Ca2+) antagonists, angiotensin converting enzyme (ACE) inhibitors, and beta 
adrenergic blockers, and other drugs (antidiabetic agents, sulfonylurea, etc.) apart from acting 
via their established mechanisms also exert positive actions connected directly or indirectly 
to endothelium [21–23]. Yet, keeping in mind the huge heterogeneity of endothelial cell phe-
notype, one must not forget that therapy affecting endothelium should be targeted to specific 
vascular beds. In the last time, endothelium-targeted nanomedicine has evolved as a promis-
ing new model to deliver drugs directly into the endothelial cells [24]. Last but not least, 
exercise has long been appreciated as one of the most efficient measures to improve endothe-
lial (dys)function in various ways: increasing nitric oxide (NO) bioavailability; induction of 
reactive oxygen species (ROS) scavenging enzymes [25]; affecting the sympathetic nervous 
system; and increasing the number of endothelial progenitor cells (EPCs) to list just a few.
In the subsequent sections of the chapter, basic concepts of endothelial (patho)physiology, rel-
evant for the book, will briefly be addressed. More detailed information on endothelial (dys)
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function, with particular emphasis on its genetic background and senescence, its involvement 
in inflammation and hemostasis, and its adaptation to various environmental challenges are 
extensively given in the following book chapters.
2. Endothelial function depends on its structural and molecular 
characteristics
Electron microscopy combined with various labeling techniques has enabled an insight into 
the endothelial structure. Along the arterial tree, the shape of endothelial cells varies from 
predominantly flat in arteries and capillaries to even cuboidal in high endothelial venules, 
a special type of postcapillary venules [1, 7]. As endothelial cells are challenged by diverse 
extracellular stimuli from their environment on a spatial and temporal basis, various signaling 
pathways finally culminate in (post)transcriptional modifications and thus marked alterations 
of the phenotype. In addition, some site-specific properties of endothelium are epigenetically 
determined. Using DNA microarray analysis, distinct gene patterns between large vessel and 
microvascular endothelial cells, as well as between blood and lymphatic endothelial cells have 
been shown [26]. While large vessels express several genes involved in the biosynthesis and 
remodeling of extracellular matrix (fibronectin, various collagens, osteonectin), microvascular 
endothelial cells abundantly express genes coding for basement membrane proteins (laminin, 
various integrins, CD36). In addition, microvascular endothelial cells were shown to express 
higher levels of transcripts encoding proteins involved in trafficking of circulating blood cells 
and pathogens which enables pathogens and immune cells to migrate to target tissues [26]. 
Interestingly, data suggest that the artery-vein identities of endothelial cells are established 
before blood circulation begins [26]. Recent findings on the organotypical differentiation of 
microvascular beds are extensively presented elsewhere [3, 27].
2.1. On endothelial permeability, inter-endothelial cell junctions, and caveolae
Given the pivotal role of the microvascular endothelium in supplying tissues with nutrients 
and oxygen, endothelial integrity is crucial for tissue-fluid homeostasis. While basal perme-
ability mainly governs water and solutes transport across the capillary wall of a healthy 
endothelium, the term inducible (or induced) permeability refers to alterations in endothelial 
permeability associated with inflammation and occurs predominantly at the site of postcapil-
lary venules [1]. The latter occurs as a consequence of endothelial cell retraction and intercel-
lular gap formation by a variety of agonists (histamine, serotonin, bradykinin, substance P, 
vascular endothelial growth factor (VEGF)) [28], or according to more recent speculations, 
due to transcellular vascular leakage of macromolecules [29].
In general, microvascular endothelial structure directs the capillary dynamics: fluids and 
small solutes (less than 3 nm) move passively across the endothelium mainly via paracel-
lular transport mechanisms or transcellularly by simple diffusion (nonpolar substances and 
gases) whereas larger macromolecules are transported by transcellular mechanisms, includ-
ing receptor-dependent and receptor-independent transcytosis [30].
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Paracellular transport pathways across the capillary wall depend on endothelial permeability. 
Permeability is mainly determined by the integrity of endothelial glycocalyx and two types of 
inter-endothelial cell junctions, the distribution of which depends on the capillary network: 
tight junctions (TJs) and adherens junctions (AJs). The main component of AJs are cadherins 
(cadherin-VE being the most abundant), which belong to adhesion molecules and are also 
connected to actin cytoskeleton [31, 32]. Changes in VE-cadherin dynamics at AJs can lead 
to disassembly of AJs, increasing the junctional permeability; chronic vascular leakage that 
occurs in tumor vessels is associated with downregulation of VE-cadherin expression [33]. 
Interestingly, endothelial NO synthase (eNOS) hyperactivation in response to vascular endo-
thelial growth factor (VEGF) or platelet aggregating factor (PAF) triggers S-nitrosylation of 
VE-cadherin, thereby causing destabilization of AJs, and leading to endothelial hyperperme-
ability [34]. In addition, ROS have been implicated in junctions disorganization [35]. As altered 
Ca2+ signaling has been implicated in inducing endothelial hyperpermeability, activation of 
transient receptor potential (TRP) channels which regulate Ca2+ entry has been associated 
with hyperpermeability states and transendothelial migration of leukocytes [31]. In addition, 
the integrity of AJs depends on small RhoGTPases that have been intensively investigated as 
potential drug targets [31]. Interestingly, statins (simvastatin) have been shown to prevent 
vascular injury associated with hyperpermeability and inflammation by affecting the RhoA- 
and Rac1-mediated cytoskeletal arrangements [36].
Transcellular transport mechanisms are accomplished by membrane-bound vesicular carri-
ers, such as caveolae and vesiculo-vacuolar organelles. Caveolae are plasma-membrane 
invaginations composed of lipids and caveolins, scaffolding proteins that are involved in 
transmembrane signaling. Caveolin has been used as molecular marker for the isolation of 
caveolae-enriched membranes from in vitro cultured cells [37].
With reference to endothelial heterogeneity, there are significant differences in the number 
of caveolae in endothelium along the vascular tree reaching up to 10,000 per cell in the capil-
laries [1]. Besides being involved in transcellular trafficking, caveolar network in endothelial 
cells affects many other endothelial functions. Caveolin can modulate signal transduction: 
G-protein-coupled receptors and receptor tyrosine kinases are localized into caveolae and 
interact with caveolin [37]. Caveolins have also been involved in cell migration, angiogenesis, 
and cancer [38]. VEGF is an important proangiogenic factor that promotes angiogenesis by 
increasing vascular permeability, endothelial cell migration, and the release of proteolytic 
matrix metalloproteinases (MMPs). VEGF receptors have been localized in caveolae and 
interact with caveolin-1 [39]. VEGF disrupts the interaction between the VEGF receptor 
(VEGFR)-2 and caveolin-1, thereby activating the downstream signaling [39]. Silencing caveo-
lin-1 has been shown to affect MMPs activity and VEGF-induced angiogenesis [40]; moreover, 
it induced morphological alterations of endothelial cells, and reduced cell migration and 
tubulogenesis induced by VEGF, pointing to an important role of caveolae in angiogenesis. 
Additional evidence on the involvement of caveolae in vasculogenesis comes from studies 
showing that the recruitment of EPCs [41], which are now widely recognized as one of the key 
mechanisms in adult vasculogenesis, to the peripheral blood is dependent on the expression 
of VEGFR2 [42]. Finally, one should not forget one of the main effects of caveolin, namely 
inhibition of eNOS [43, 44]. As caveolin also interferes with adenosine receptor trafficking and 
the role of adenosine has been implicated in ischemia and inflammation, caveolar network 
may represent a potential therapeutic target [45].
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In addition, being part of the mechanosensory complex, caveolae and AJs are involved in 
mechanosensing [31, 46]: exposure of endothelial cells to shear stress has been shown to affect 
the number and distribution of caveolae [47, 48].
2.2. On endothelial barrier and mechanosensing
Mechanosensing is accomplished by a complex mechanism involving parts of endothelial 
cells, which convey the mechanic signals sensed by surface cellular elements in the transduc-
tion intracellular signaling pathways, finally adjusting the endothelial response to alterations 
of shear-stress. Mechanosensing complex, located in AJs, is composed of endothelial glycoca-
lyx and endothelial cilium, VE-cadherins, VEGFR2 and platelet endothelial cell adhesion mol-
ecules (PECAM-1 or CD31), and various ion channels: the role of Ca2+-dependent potassium 
channels (K+Ca) and TRP channels has extensively been investigated [10, 48]. However, certain 
predilection sites are prone to the generation of characteristic spatiotemporal shear-stress pat-
terns favoring atherogenesis [9, 10, 48, 49].
Glycocalyx, a 50–100 μm thick structure anchored in the endothelial plasma membrane and 
composed of carbohydrate-rich proteoglycans, is located at the luminal surface of the endo-
thelium [2, 30, 50]. It is importantly involved in mechanosensing, in the regulation of perme-
ability, and inflammatory response [32, 48, 50] and has also been investigated as a potential 
therapeutic target [51, 52]. It prevents leucocyte and platelet adhesion [53] and mediates 
shear-stress-induced NO release, thus exerting vasculoprotective effects and contributing to 
vascular homeostasis [10, 54]. Besides being susceptible to pathological alterations in blood 
flow, other environmental alterations affect its composition and thus function, e.g., high glu-
cose has been shown to be involved in glycocalyx degradation contributing to lower NO 
bioavailability in hyperglycemia [55, 56]. Recent concept has confirmed the existence of an 
additional thicker (0.5–1 μm) layer on the luminal endothelial surface (termed endothelial 
surface layer, ESL) which significantly impacts hemodynamic conditions, oxygen transport, 
vascular control, coagulation, inflammation, and atherosclerosis [2].
Endothelial cilium is a single hair-shaped projection from the cellular surface of endothelial 
cells. Besides being involved in sensing hemodynamic forces, it coordinates cell migration and 
division [30, 57]. Impaired function of the primary cilium, either genetically or due to environ-
mental factors, results in developmental disorders or endothelial dysfunctions, respectively. 
The main components of the primary cilium are various membrane receptors (specific receptor 
tyrosine kinases, as platelet-derived growth factor (PDGF) receptor α, fibroblast growth factor 
receptor; insulin-like growth factor 1 (IGF-1) receptor; G-protein coupled receptors), channel 
proteins (polycystin-1 and -2), and special arrangement of the microtubules [30, 57]. Both 
polycystin proteins are importantly involved in intracellular signaling: polycystin-2, in turn, 
belongs to the TRP channel family which, by interacting with polycystin-1, increases intracel-
lular Ca2+ leading to the activation of ryanodine receptors on the endoplasmic reticulum. The 
released Ca2+ subsequently activates a number of signaling pathways, among others the shear-
stress induced activation of eNOS and an increase in NO production [57, 58]. Alterations in 
the patterns and magnitude of biomechanical forces induce disorganization in cilia structure: 
prolonged exposure to increased shear stress induces disassembly of cilia, rearrangement of 
cytoskeleton, and increased acetylation of microtubules [59]. Dysfunctional cilia have been 
implicated in kidney disease, hypertension, and the development of atherosclerosis [60].
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In addition to being part of endothelial cilium, microtubules polymerized with heterodimers of 
alpha- and beta-tubulins are important cytoskeletal proteins in endothelial cells. They regulate 
numerous cellular functions, including cell shape, adhesion, intracellular transport, mitosis, and 
migration and thus contribute to endothelial integrity [35, 61]. Increased level of tubulin acetyla-
tion has been shown to increase cell migration [62]. On the other hand, cyclic stretch and angio-
tensin II (AngII) have been shown to increase tubulin deacetylation and tubular reorganization, 
predisposing to the development of cardiovascular diseases [63]; potential role on the AngII 
type 1 receptor antagonist in positively affecting endothelial microtubular organization has been 
implicated [63]. The longevity regulator sirtuin 1 (SIRT1), a potential therapeutic target [64], has 
been implicated in tubulin deacetylation and the regulation of microtubule function [63].
Disturbed flow patterns and increase of shear-stress have been acknowledged to affect the above 
targets, thus contributing to endothelial dysfunction in many ways, including increased genera-
tion of ROS, promoting cytoskeletal disassembly, increasing cellular permeability, expression of 
adhesion molecules and inflammation, as well as inducing mitogenic signaling pathways through 
extracellular signal-regulated kinase (ERK) and Jun kinase (JNK) involved in vascular remodel-
ing which all favor atheroma formation [65]. Moreover, there is ample evidence that nonlaminar 
flow can result in gene expression of pro-inflammatory molecules in the vascular wall [49, 65].
2.3. On endothelium and inter-cellular communication
As mentioned, endothelial homeostasis involves mutual communication with other cells.
Gap junctions in turn enable a direct transmission of electrical and chemical signals and thus 
exchange of ions and other small molecules between endothelial cells, VSMC, and pericytes 
[8, 30, 66]. The main components of endothelial gap junctions are connexins (Cx) which have 
been shown to be defective in diseased states and thus represent a potential therapeutical 
target. A total of 21 connexins have been identified in humans displaying cellular specificity 
[67]. Healthy endothelium mainly expresses Cx-37 and Cx-40 [67, 68]. Alterations in connexin 
expression might be associated with endothelial dysfunction and increased susceptibility to 
atherosclerosis: altered expression of Cx-37 was shown to decrease NO bioavailability by 
decreasing eNOS activity [69], whereas endothelial-specific deletion of Cx-40 was reported to 
increase CD73-dependent leukocyte adhesion to endothelium [70].
Pericytes are contractile cells that wrap around the endothelial cells of capillaries and venules 
by sharing their basement membrane [71, 72]. As there is a considerable paracrine signaling 
between both cell lineages (via the release of transforming growth factor, angiopoietins, PDGF, 
sphingosine-1-phosphate), pericytes have been implicated in the regulation of capillary blood 
flow, and in the maturation and survival of endothelial cells by modulating apoptosis, and 
promoting angiogenesis [71–73]. Disturbance in pericyte-endothelial communication induces 
various pathological processes, associated with increased proneness to hemorrhage, apopto-
sis, impaired (tumor) angiogenesis, and endothelial hyperplasia [73].
An important communication exists between the perivascular adipose tissue (PVAT), endothe-
lial cells, and VSMCs: PVAT secretes a number of adipokines (tumor necrosis factor, TNFα, 
interleukin-6, IL-6, resistin, irisin) with various pro- and antiatherogenic properties [8, 11]. 
The level of adipocytokines has been suggested as an independent predictor of endothelial 
dysfunction in healthy subjects [17]. In a healthy individual, PVAT importantly influences 
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metabolism [74] and inflammatory response and modifies vascular tone regulation by secret-
ing protective adipokines which exert paracrine actions directly and indirectly by stimulating 
the release of endothelial vasodilators on VSMC [75, 76]. Moreover, healthy PVAT has been 
shown to enhance insulin-induced vasodilation by releasing adipokines [77], as well as pros-
tacyclin (PGI
2
) [74]. Adiponectin, the most abundant adipokine, has been shown to decrease 
tissue inflammation [78]. However, these anti-contractile and anti-inflammatory properties 
of PVAT are blunted in disease, such as obesity, and hypertension where an imbalance of 
secreted adipokines from PVAT and alterations in metabolism predispose to inflammation 
and the development of endothelial dysfunction [79]. Hypoxia is one of the main mechanisms 
increasing the release of inflammatory cytokines (IL-6 and TNFα) from PVAT [80], and induc-
ing macrophage activation which all favors a pro-inflammatory and pro-contractile state [81]. 
Moreover, in response to vascular injury [82] or high fat diet [83], PVAT has been shown to 
express pro-inflammatory phenotype and a significant reduction of adiponectin levels lead-
ing to atherosclerosis. Interestingly, the inflammatory profile of PVAT has been shown to dif-
fer between distinct fat depots [84]. Independent human studies have proven beneficial effects 
of exercise and diet on PVAT, and consequently also on endothelial dysfunction [85, 86].
Endothelial and VSMC are abundantly innervated with the fibers of the sympathetic nervous 
system, and there is a considerable and complex cross talk between various neurotransmit-
ters released from these fibers and endothelial autacoids [87–89]. Besides noradrenaline, that 
binds on various adrenoceptors on endothelial cells and VSMC, other transmitters (such as 
adenosine triphosphate (ATP), calcitonin gene-related peptide (CGRP) acetylcholine (ACh), 
and neuropeptide Y) are released from nerve varicosities, thereby profoundly modulating 
endothelial function. Noradrenaline was shown to activate β
3
-adrenergic receptors on endo-
thelium, thereby increasing NO production [89, 90], while the co-transmitted ATP mediates 
endothelial hyperpolarization by acting on endothelial purinoceptors (P2Y) [88]; both effects 
finally induce vasorelaxation and, respectively, modulate the “classical” sympathetic vaso-
constrictor effects on VSMC. Moreover, NO affects neurotransmission at the level of blood 
vessels, acting on presynaptic α
2
-adrenergic receptors, and it also interferes with the sympa-
thetic neurotransmission in the central nervous system [87].
Endothelial dysfunction and autonomic nervous system imbalance often coexist in the devel-
opment of cardiovascular diseases [88]. Indeed, an inverse relationship between markers of 
endothelial function and the sympathetic activity in healthy conditions is well known: in young 
adults, acute increase of the sympathetic activity, as assessed by measuring the plasma nor-
adrenaline concentration, has been shown to impair endothelium-dependent dilation [91, 92]. 
Sympathetic nervous system activity is also proposed to be an important factor contributing 
to endothelial dysfunction with age [92].
2.4. Other endothelial functions: involvement in hemostasis, inflammation, and 
angiogenesis
Endothelium maintains blood fluidity, preventing intravascular coagulation and thrombus 
formation, respectively; endothelial cells express a variety of intraluminal surface proteins 
(such as thrombomodulin) and secrete molecules with anticoagulant and antithrombotic 
properties: ectonucleotidases and protein C and S as well as substances which inhibit platelet 
adhesion and aggregation (PGI
2
 and NO).
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On the other hand, endothelium enables hemostasis when needed through the expression of 
specific membrane glycoproteins which enable adhesion of platelets to the damaged vascular 
wall (i.e., subendothelial matrix); and secretion of diverse substances, such as vWF, thrombin, 
tissue factor, and many others. Additionally, endothelium plays a crucial role in the fibri-
nolytic system. Nevertheless, prothrombotic, procoagulation, and antifibrinolitic states are 
associated with thrombi formation and cardiovascular events.
Endothelium is importantly involved in inflammatory processes and tissue repair as it adjusts 
changes in vascular reactivity and permeability in response to various cytokines and auta-
coids, increasing plasma extravasation and larger molecules trafficking as well as the adhesion 
and recruitment of leucocytes across the vessel walls, mainly of the postcapillary venules to 
the site of injury/inflammation. It itself produces many substances involved in inflammation 
and subsequent tissue repair, i.e., VEGF and various cytokines (e.g., IL-1, TNF-α). Moreover, 
cytokines released from endothelium in an autocrine manner augment the inflammatory 
response by affecting intracellular signaling pathways which activate various transcription 
factors, especially the transcription factor NF-kB, to finally increase the expression of proadhe-
sive and procoagulant genes. In addition, cytokines and VEGF also promote endothelial and 
VSMC proliferation [93]. In response to inflammation, endothelial cells increase the expres-
sion of a variety of adhesion molecules, belonging to three gene families, namely selectins, 
integrins, and the immunoglobulin (Ig) superfamily (comprising VCAM, intercellular adhe-
sion molecules (ICAM), and PECAM-1) on their surface which enable leucocytes to recognize 
the affected sites, adhere to endothelium and cross the vessel wall. As the level of circulating 
adhesion molecules is increased in diseases, they have been used as a marker of endothelial 
dysfunction. Inappropriate regulation of inflammatory processes has been acknowledged as 
an early step in the development of atherosclerosis as well as other pathological processes [94].
Endothelium is crucial for vasculo- and angiogenesis. Postnatally, endothelial cells are rela-
tively quiescent and the growth of new vessels (neoangiogenesis) in healthy adults only 
occurs in uterine cycle, reproduction (i.e., placenta formation), and wound healing, as well as 
in response to repeated exercise and endurance training in myocardium and skeletal muscles. 
Neoangiogenesis requires a fine orchestrated interplay between endothelial cells, VSMC, 
pericytes, and a variety of signaling molecules, including growth factors [95], chemokines, 
angiopoietins, semaphorins, angiogenic enzymes, adhesion molecules, ephrins, and MMPs 
[93]. Neoangiogenesis involves many interdependent processes; in brief, upon stimulation 
by various angiogenic growth factors, endothelial cells get activated and release protease 
to degrade and invade basal lamina and the underlaying extracellular matrix. Endothelial 
cells then migrate into the interstitial space, where they proliferate and differentiate to form 
solid sprouts connecting neighboring vessels [38, 93, 96]. The role of VEGF and angiopoietins 
and the involvement of caveolae have shortly been mentioned above. In addition, circulating 
EPCs have also been shown to play a role in angiogenesis as they can differentiate to mature 
endothelial cells and replace injured or senescent endothelial cells [41, 97]. The number of 
circulating EPCs has been shown to be increased in cancer [98]. One of the most important 
(patho)physiological stimuli for neoangiogenesis in adult period is hypoxia which modi-
fies gene expression dependent on the activation of hypoxia-inducible factor-1 (HIF-1) and, 
among others, it triggers endothelial cells to get activated [99]. Excessive angiogenesis in adult 
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period also occurs in many pathological conditions, such as cancerogenesis, tumor growth, 
and metastasis. To this end, the processes connected to angiogenesis represent an important 
therapeutic niche: on one side, antiangiogenic drugs are targeted against tumor growth [100], 
and on the other, proangiogenic drugs have to be designed to augment the angiogenic poten-
tial [101].
Endothelial cells also express enzymes for degradation of other autacoids, and enzymes 
which convert humoral factors to attend their full activity, as, e.g., ACE.
Endothelium, therefore, is a highly metabolic organ. Energy supply for its pleiotropic func-
tions is derived mainly from glucose by anaerobic metabolism although endothelium is 
directly exposed to blood with high oxygen partial pressure (pO
2
); therefore, enough O
2
 to be 
transported to other cells may be conserved [102]. Fatty acids represent another potential fuel 
for endothelial cells; yet, as they have relatively few mitochondria, fatty acids have been pro-
posed to only modestly contribute to total ATP generation [102]. Glucose is transported into 
endothelial cells via insulin-independent GLUT-1 transporter [103]; respectively, endothelial 
cells, particularly the microvascular ones [104], are susceptible to adverse effects of hypergly-
cemia which in multiple ways increases the level of oxydative stress. The mechanism involves 
mitochondrial hyperpolarization, which affects ROS production [105, 106]. However, ROS 
should not only be regarded as a foe: in recent years, they have been acknowledged as impor-
tant players in endothelial homeostasis, modulating endothelium-dependent vasodilation, 
permeability, and angiogenesis [105, 106]. On the other hand, dysfunctional mitochondria 
have been implicated in endothelial dysfunction and vascular aging [107–109] and as such 
represent a potential therapeutic target [109]. Moreover, mitochondria might be regarded as 
oxygen sensors since in hypoxic conditions, the generation of ROS is increased and connected 
to hypoxia-mediated responses, such as increased permeability, changes in cell surface adhe-
sion molecules, cell proliferation, and angiogenesis [110]. Exercise and diet have been shown 
to beneficially impact mitochondria dysfunction [108, 111]. Caloric restriction has also been 
connected with SIRT1: decreased ATP level activates AMP-activated protein kinase (AMPK), 
the main cellular energy sensor which in turn activates SIRT1 [112].
3. Endothelium and vascular tone regulation: endothelial 
vasodilators
One of the main functions of endothelium is its involvement in vascular tone regulation. 
In response to mechanical and pharmacological (ACh, histamine, bradykinin, VEGF, vari-
ous hormones as estrogen, CGRP, substance P, insulin, and platelets products (serotonin, 
ADP)) stimuli, endothelium releases a number of vasoactive mediators which, by affecting 
VSMC, regulate vascular tone and thus help to adjust blood flow to tissue demands. There 
is a considerable and complex interplay between endothelial and other humoral vasoac-
tive substances, as well as the sympathetic nervous system. Mostly investigated endothe-
lial vasodilators are NO, PGI
2
, and endothelium-derived hyperpolarizing factor(s) (EDHF), 
whereas the main constrictors include endothelin, thromboxane, AngII, the cytochrome P450 
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(CYP)-hydroxylase-derived 20-hydroxyeicosatetraenoic acids (20-HETE) [113, 114], and con-
strictor prostanoids [115]. In a healthy state, vasodilators predominate whereas in endothelial 
dysfunction, reduced vasodilator bioavailability, in particular NO and an excessive release of 
vasoconstrictors result in an increased vascular tone. Moreover, in the settings of endothelial 
dysfunction, other vasodilators may compensate for the reduced NO bioavailability [116–118].
Endothelial vasodilators mediate the endothelium-dependent vasodilation. Yet, it must be 
noted that the contribution of each to the regulation of vascular tone differs between the vas-
cular beds: while NO has mainly been implicated in the regulation of larger vessels, other 
vasodilators seem to play the prominent role in microcirculation [116, 117, 119].
FMD denotes endothelium-dependent decrease of vascular tone in response to increased 
blood flow, which is noted down—as well as upstream of the vessel tree, and has been used 
as a surrogate marker of endothelial function in the clinics. It is mostly tested by performing 
a transient occlusion of a distal (or proximal) artery to induce local ischemia and assessing 
blood flow increase after reperfusion. The phenomenon of postocclusive hyperemia (PORH) 
is a good example to explain the mechanism of FMD: endothelium-dependent vasodilation 
elicited by increased shear stress due to increased flow as a consequence of the vasorelaxant 
effect of locally accumulated metabolites additionally increases the flow to meet tissue meta-
bolic demands and simultaneously oppose the pressure-induced myogenic vasoconstrictory 
response [116].
3.1. Nitric oxide exerts many vasoprotective functions
NO is constantly being formed from the amino acid L-arginine by constitutively expressed 
eNOS. It can also be produced by other isoforms of NOS, namely inducible (iNOS) and neu-
ronal (nNOS), present in various cell types (endothelial cells, platelets, neurons and VSMC, 
macrophages, polymorphonucleated leukocytes) which are important in the settings of 
endothelial activation and/or dysfunction [43]. eNOS is a calmodulin-dependent enzyme 
requiring cofactors as Ca2+, tetrahydrobiopterin (BH
4
), nicotinamide adenine dinucleotide 
phosphate (NADP), etc. Its activity is regulated by complex interactions of the endothelial 
microdomain proteins whereby its association with the heat-shock protein increases and with 
the caveolin-1 decreases its activity [44]. Moreover, it is modulated posttranslationally in a 
Ca2+-dependent way through the activation of various Ca2+-channels on the cell membrane 
and by Ca2+-independent way which is the main mechanism of shear-stress-induced eNOS 
activation. The Ca2+-independent pathway mainly affects the phosphorylation of eNOS by 
Akt kinase, Ca2+/calmodulin-dependent protein kinase II (CaMKII), protein kinase A (PKA), or 
AMPK, depending on the stimulus; a variety of stimuli, including hormones, growth factors, 
purines, histamine, bradykinin, serotonin, noradrenaline, etc., affect G-protein-coupled recep-
tors and finally activate the corresponding target to subsequently phosphorylate eNOS and 
increase its activity [43]. On the other hand, hyperglycemia has been suggested to adversely 
affect eNOS phosphorylation thus attenuating NO production [120]. Another common post-
translational modification of eNOS activity is acetylation/deacetylation: for example, SIRT-1, 
a class III histone deacetylase enhances the ACh- and shear-stress-induced-NO production by 
deacetylating eNOS, thereby enhancing its binding to calmodulin [121]. Moreover, aspirin has 
been shown to enhance eNOS activation by acetylating eNOS, independently of its effect on 
cyclooxygenase inhibition [122].
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Of note is the dual role of eNOS: when the bioavailability of its substrates and/or cofactors 
is reduced and in conditions of increased oxidative stress, eNOS can get uncoupled and pro-
duces superoxide anion (O2−) instead of NO; O2− is a highly reactive radical which forms 
peroxynitrite (ONOO−) with NO, and in this way, it additionally decreases the bioavailability 
of NO and contributes to endothelial dysfunction [43, 44, 90].
Besides directly inducing vascular relaxations by activating the soluble guanylate cyclase 
(sGC) in VSMC, NO importantly modulates other endothelial autacoids (e.g., PGI
2
, EDHF, 
endothelin) affecting vascular tone [123, 124], and interferes with the sympathetic neurotrans-
mission pre- and postsynaptically [89].
NO exerts other effects: it inhibits platelet aggregation (interestingly, activated-platelet-
derived substances increase the activity of eNOS, thus producing more NO) and the adhesion 
of leucocytes to the vascular wall by decreasing the expression of adhesion molecules on 
endothelial surface [90]. Moreover, it interferes with cellular metabolism [125] by modulat-
ing mitochondrial function, and oxygen metabolism [106, 126]. As stated, NO forms ROS 
(ONOO−) with increased levels of O2− which, among others, impairs the mitochondrial respi-
ratory chain [127]. On the other hand, the depolarization of mitochondrial membrane induced 
by mitochondrial KATP-channel activators has been reported to increase the activity of eNOS in 
rat cerebral arteries [128]. Other gaseous mediators involved in vascular tone regulation have 
also been proposed to interfere with the mitochondrial function [127].
In the settings of hypoxia, NO could alternatively be derived from the reduction of ONOO− 
which may partly compensate for reduced eNOS activity [129].
A number of factors have been known to exert beneficial vasoprotective effects by interfering 
with eNOS activity and consequently increasing NO bioavailability, including female sex hor-
mones (the protecting effects of estrogens have long been appreciated), insulin, glucagon-like 
peptide, thyroid hormones, erythropoietin, high density lipoproteins, etc., as well as endothe-
lial exposure to repetitive increases in shear stress as occurs in exercise [25, 130].
On the other hand, many factors negatively impact eNOS or scavenge NO, thereby reducing 
the beneficial effects of NO: ROS, reduced availability of BH
4
 or arginine, due to increased 
levels of arginase, asymmetric dimethylarginine (ADMA), an endogenous inhibitor of 
eNOS, cortisol, aldosterone, and numerous others. Moreover, environmental factors, such 
as smoking, radiation, increased salt intake or hyperglycemia, as well as other metabolic 
disturbances, such as insulin resistance and metabolic syndrome, hypercholesterolemia and 
obesity, homocysteinemia, uric acid, diminish the NO-dependent vasodilation and other 
NO-associated effects [130]. The latter settings predispose to endothelial dysfunction and the 
development of diseases, such as hypertension and atherosclerosis, and increase the risk for 
cardiovascular events.
Therefore, the biosynthetic pathways of NO and its downstream targets might all represent 
potential therapeutic targets [90, 131].
Increased levels of ROS could be regarded as a common denominator of reduced NO bioavail-
ability resulting in endothelial dysfunction. Fortunately, the endogenous ROS-scavenging 




) which is proposed as one of important endo-
thelial factors inducing VSMC hyperpolarization and vasodilation, respectively [75, 132, 133]. 
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The bad ROS are turned into the good ones thus ameliorating their damaging effects [133]. 




 have also been suggested to overtake the role of NO in the 
settings of reduced NO bioavailability also in humans [134].
3.2. Endothelium-dependent relaxations beyond NO: hyperpolarization
Shear stress and various agonists also stimulate the production of other vasodilators, among 
which the derivatives of arachidonic acid (AA) play an important role.
AA is liberated from membrane phospholipids by the action of Ca2+-stimulated phospholi-
pase A
2
, and subsequently metabolized into biologically active eicosanoids with a variety of 
functions. Three main complex enzymatic pathways of AA metabolism are the cyclooxygen-
ase pathway, the cytochrome (CYP)-P450 pathway, and the lipoxygenase pathway; however, 
AA can be transformed into isoprostanes nonenzymatically by ROS [135]. Regarding vascu-
lar tone regulation, AA metabolites include a number of vasodilators and vasoconstrictors 
[113–115, 135–138].
One of the most investigated AA metabolites is PGI
2
, formed by prostacyclin synthase, which 
belongs to the CYP-450 family and is highly expressed in endothelial cells and associated 
with cyclooxygenase (COX)-2 [115, 135–137]. Its vasodilator effects mainly involve binding 
to prostacyclin (IP) receptors and activation of adenylate cyclase increasing cAMP level in 
VSMC and subsequent relaxation. Yet, the role of PGI
2
 as endogenous mediator of endothe-
lium-dependent vasodilation in vivo has often been questioned and its other effects, such 
as inhibition of platelet adhesion and aggregation, and reduction of oxidative stress [135, 
139] might rather account for its vasculoprotective effects. Moreover, COX-2-derived PGI
2
 
might play a compensatory role for the decreased NO bioavailability [117, 118]. To this end, it 
must be noted that other prostanoids from the COX metabolic pathways also affect vascular 
tone: due to various metabolic pathways as well as various prostaglandin receptors coupled 
to different signaling pathways, they might either induce vasoconstriction or vasodilation 
[115, 135, 137–139]. It is the delicate balance between vasoconstrictors and vasodilators which 
enables normal functioning of healthy endothelium; in endothelial dysfunction, the effect of 
vasoconstrictive prostanoids predominates, predisposing to the development of hyperten-
sion, atherosclerosis, and various other diseases.
Besides NO and PGI
2
, endothelial hyperpolarization (EDH) accounts for endothelium-
dependent, flow-mediated vasodilation; by blocking eNOS (by L-NMMA) and COX (by more 
or less specific COX inhibitors), the role of non-NO-non-PGE-dependent vasodilation has 
unequivocally been confirmed not only in in vitro assays and in animal models but also in vivo 
in various human vessels during resting [140–143] and exercise [144].
Many of endothelial mediators and signals are known to induce the hyperpolarization of 
VSMC [8, 130, 135, 136, 145, 146]: epoxyeicosatrienoic acids (EETs) produced in the CYP-450-




 [133, 140], potassium 
ions released from the endothelial cells via K
ca
 channels, and direct transmission of endo-
thelial cell hyperpolarization by myoendothelial gap junctions. Thus, EDHF comprises a 
variety of factors which activate various potassium channels: small (SKCa), intermediate, and 
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large-conductance K
ca
 channels; inward rectifier K+ channels (KIR) [147], and TRPV4 channels 
[148] have been implicated in finally inducing EDH. To this end, the corresponding channels 
have been investigated as potential targets to affect EDH [147, 149]. Endothelial hyperpo-
larization can spread via myoendothelial gap junctions to directly induce VSMC hyperpo-
larization: the role of gap junctions has been implicated also in humans in vitro and in vivo 
as carbenoxolone, a nonspecific gap junction blocker, diminished conducted vasodilation in 
isolated human coronary arterioles [150], and, moreover, reduced FMD in the brachial artery 
of healthy volunteers [151]. The term conducted dilation has been used to denote electrotonic 
transmission of local hyperpolarization, and may spread several mm upstream independent 
of alterations in shear stress [116, 119, 152]. It reflects the involvement of gap junctions and 
enables a coordinated adjustment of vascular resistance in larger and smaller arterioles and 
capillaries [153].
Age and gender might affect the EDHF-mediated response as male animals were reported 
to exhibit smaller EDHF-mediated endothelium-dependent relaxation compared to females; 
similarly, aging affected EDH. A reduced SKCa activity and a reduced expression of gap junc-tion proteins, Cx-40 and Cx-43, have been suggested to account for these differences [154]. 
Moreover, 17b-estradiol has been proposed to activate AMPK and/or SIRT1, both implicated 
to be involved in increasing the EDHF-mediated signaling [154]. Alteration of the EDH con-
tributes to endothelial dysfunction observed in various pathologies [145, 154].
Finally, other endothelium-derived vasodilators should be listed: adenosine and purines, 
various peptides, including CGRP, C-type natriuretic peptide (CNP), adrenomedullin, endo-
cannabinoids, and gaseous transmitters other than NO, namely hydrogen sulfide (H
2
S), and 
carbon monoxide (CO) which have been suggested to compensate for decreased NO bioavail-
ability [127, 155, 156]. Adenosine, one of the most potent vasodilators (exerting also other 
vasculoprotective effects) is mainly formed from extracellular nucleotides (ATP, AMP) by the 
action of ectonucleotidases, expressed in endothelial cells and also investigated as potential 
therapeutic targets [157]. Interestingly, circulating ATP itself has been proposed to mediate 
vasodilation in humans in vivo by inducing vascular hyperpolarization via activation of KIR 
channels [158].
4. Conclusion
By spreading throughout the vascular system and exerting pleiotropic functions, the endothe-
lium could be regarded as one of the main players in cardiovascular physiology. The integrity 
of endothelium is crucial for vascular homeostasis and health. On the other hand, endothe-
lial cells are susceptible to changes in blood composition and hemodynamic forces and as 
such vulnerable to developing endothelial dysfunction. Endothelial dysfunction nowadays is 
acknowledged a key initiating event in atherosclerosis, and connected to several pathologi-
cal conditions and cardiovascular events. Accordingly, understanding endothelial function 
and dysfunction is crucial for recognition and treatment, or, optimally, for prevention of the 
development of cardiovascular diseases, the leading cause of death worldwide. To this end, 
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it should be emphasized that the mechanistic studies on isolated vessels or on animal models 
cannot always be extrapolated directly to humans. Therefore, in spite of intensive investiga-
tions, additional studies to elucidate mechanisms of endothelial function and dysfunction are 
necessary to accomplish endothelium-targeted interventions.
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